Platelet membrane-derived nanodiscs for neutralization of endogenous autoantibodies and exogenous virulence factors

Summary

This experimental study fashions natural platelet membrane into nanodiscs that act as decoys for agents targeting platelets. The authors test two biologically different threats. In an autoimmune application, the discs bound anti-platelet antibodies and prevented those antibodies from attacking circulating platelets. In a mouse model of thrombocytopenia, treatment avoided platelet depletion and maintained hemostatic function. In an infectious application, the same membrane-derived structures neutralized cytotoxic virulence factors secreted by methicillin-resistant Staphylococcus aureus. Mice with MRSA infection experienced a significant survival benefit after nanodisc treatment. Acute-toxicity studies also supported biocompatibility and short-term biosafety in mice. The principal finding is that retained platelet membrane features can absorb both endogenous autoantibodies and exogenous bacterial factors, despite the very different origins of those pathogenic agents. This broadens platelet mimicry from targeted delivery toward biological neutralization and suggests one natural membrane platform may address multiple platelet-directed injuries. The abstract does not identify the neutralized virulence factors, quantify binding capacity or coagulation effects, compare standard treatments, or establish chronic safety, pharmacokinetics, and efficacy outside the two mouse models.